AMENDMENT NO. 3 TO THE AMENDED AND RESTATED INVESTORS' AGREEMENTCharles River Laboratories International Inc • March 27th, 2002 • Biological products, (no disgnostic substances) • Delaware
Company FiledMarch 27th, 2002 Industry Jurisdiction
Warrant AgentWarrant Agreement • December 8th, 1999 • Charles River Laboratories Holdings Inc • New York
Contract Type FiledDecember 8th, 1999 Company Jurisdiction
DATED THE DAY OF 2002 --------------------------------------------------------- ----------------------- BETWEEN/ (1) THE PARTIES LISTED IN THE FIRST SCHEDULE (2) CHARLES RIVER EUROPE GMBH AND (3) CHARLES RIVER LABORATORIES INC. SHARE PURCHASE...Share Purchase Agreement • August 12th, 2002 • Charles River Laboratories International Inc • Biological products, (no disgnostic substances)
Contract Type FiledAugust 12th, 2002 Company Industry
EXHIBIT 10.4 JOINT VENTURE AGREEMENT THIS AGREEMENT, entered into this 24th day of June, 1981, between: AJINOMOTO CO., INC., a Japanese corporation having its principal place of business at 5-8, Kyobashi 1-chome, Chuo-ku, Tokyo, Japan (hereinafter...Agreement • April 25th, 2000 • Charles River Laboratories Holdings Inc • Blank checks
Contract Type FiledApril 25th, 2000 Company Industry
COMMON STOCKCharles River Laboratories International Inc • July 6th, 2001 • Biological products, (no disgnostic substances) • New York
Company FiledJuly 6th, 2001 Industry Jurisdiction
ANNEX I U.S. $156,100,000 AMENDED AND RESTATED CREDIT AGREEMENT, dated as of February 2, 2001 (amending and restating the Credit Agreement, dated as of September 29, 1999),Credit Agreement • February 15th, 2001 • Charles River Laboratories International Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 15th, 2001 Company Industry Jurisdiction
EXHIBIT 10.4 CHARLES RIVER LABORATORIES, INC. 13 1/2% SENIOR SUBORDINATED NOTES DUE 2009 Guaranteed to the extent set forth herein by SBI HOLDINGS, INC. SIERRA BIOMEDICAL, INC. SIERRA BIOMEDICAL SAN DIEGO, INC.Indenture • December 8th, 1999 • Charles River Laboratories Holdings Inc • New York
Contract Type FiledDecember 8th, 1999 Company Jurisdiction
by and among Charles River Laboratories, Inc. as BuyerStock Purchase Agreement • February 15th, 2001 • Charles River Laboratories International Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledFebruary 15th, 2001 Company Industry Jurisdiction
INTRODUCTIONConsulting Agreement • November 1st, 2004 • Charles River Laboratories International Inc • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledNovember 1st, 2004 Company Industry Jurisdiction
CHARLES RIVER LABORATORIES, INC. and CHARLES RIVER LABORATORIES HOLDINGS, INC. as Issuers $150,000,000 150,000 Units Consisting of 13 1/2% Senior Subordinated Notes due 2009 and Warrants to purchase 591,366 shares of Common StockPurchase Agreement • December 8th, 1999 • Charles River Laboratories Holdings Inc • New York
Contract Type FiledDecember 8th, 1999 Company Jurisdiction
EXHIBIT 10.6 JOINT VENTURE AGREEMENT JOINT VENTURE AGREEMENT THIS AGREEMENT, entered into this 24th day of June, 1981, between: AJINOMOTO CO., INC., a Japanese corporation having its principal place of business at 5-8, Kyobashi 1-chome, Chuo-ku,...Joint Venture Agreement • January 28th, 2000 • Charles River Laboratories Holdings Inc • Blank checks
Contract Type FiledJanuary 28th, 2000 Company Industry
AS ISSUER,Indenture • March 27th, 2002 • Charles River Laboratories International Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 27th, 2002 Company Industry Jurisdiction
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. as the Company and U.S. BANK NATIONAL ASSOCIATION as Trustee Subordinated Indenture Dated as of ____________ __, 20__Charles River Laboratories International, Inc. • May 4th, 2021 • Services-commercial physical & biological research • New York
Company FiledMay 4th, 2021 Industry JurisdictionSUBORDINATED INDENTURE, dated as of ______ __, 20__, between Charles River Laboratories International, Inc., a Delaware corporation, as the Company, and U.S. Bank National Association, a national banking association, as Trustee.
ANNEX I AMENDMENT NO. 4 TO AMENDED AND RESTATED CREDIT AGREEMENT THIS AMENDMENT NO. 4 TO AMENDED AND RESTATED CREDIT AGREEMENT (this "AMENDMENT"), dated as of June 5, 2002, among Charles River Laboratories, Inc., a Delaware corporation (the...Credit Agreement • August 12th, 2002 • Charles River Laboratories International Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 12th, 2002 Company Industry Jurisdiction
RECITALSAgreement and Plan of Reorganization • June 23rd, 2000 • Charles River Laboratories International Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJune 23rd, 2000 Company Industry Jurisdiction
EXHIBIT 10.10 AMENDED AND RESTATED DISTRIBUTION AGREEMENTDistribution Agreement • December 8th, 1999 • Charles River Laboratories Holdings Inc
Contract Type FiledDecember 8th, 1999 Company
AMENDMENT NO. 1 TORecapitalization Agreement • December 8th, 1999 • Charles River Laboratories Holdings Inc • New York
Contract Type FiledDecember 8th, 1999 Company Jurisdiction
AMENDMENT NO. 2 TO AMENDED AND RESTATED CREDIT AGREEMENT AND AMENDMENT NO. 1 TO AMENDED AND RESTATED HOLDCO GUARANTY AND PLEDGE AGREEMENTCredit Agreement • March 27th, 2002 • Charles River Laboratories International Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 27th, 2002 Company Industry Jurisdiction
WITNESSETH:Agreement and Release • June 6th, 2000 • Charles River Laboratories International Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledJune 6th, 2000 Company Industry Jurisdiction
PART II AMENDMENTS TO EXISTING CREDIT AGREEMENTCredit Agreement • May 9th, 2002 • Charles River Laboratories International Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 9th, 2002 Company Industry Jurisdiction
EXHIBIT 10.1 CREDIT AGREEMENT dated as of March 31, 2003Credit Agreement • May 5th, 2003 • Charles River Laboratories International Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 5th, 2003 Company Industry Jurisdiction
dated as of June 19, 2000 amongInvestors' Agreement • June 23rd, 2000 • Charles River Laboratories International Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJune 23rd, 2000 Company Industry Jurisdiction
COMMON STOCKCharles River Laboratories International Inc • March 15th, 2001 • Biological products, (no disgnostic substances) • New York
Company FiledMarch 15th, 2001 Industry Jurisdiction
SEVENTH AMENDED AND RESTATED CREDIT AGREEMENT dated as of March 30, 2016 among CHARLES RIVER LABORATORIES INTERNATIONAL, INC., The Subsidiary Borrowers Party Hereto, The Lenders Party Hereto, JPMORGAN CHASE BANK, N.A., as Administrative Agent BANK OF...Credit Agreement • April 5th, 2016 • Charles River Laboratories International Inc • Services-commercial physical & biological research • New York
Contract Type FiledApril 5th, 2016 Company Industry JurisdictionSEVENTH AMENDED AND RESTATED CREDIT AGREEMENT, dated as of March 30, 2016, among CHARLES RIVER LABORATORIES INTERNATIONAL, INC., the Subsidiary Borrowers party hereto, the Lenders party hereto and JPMORGAN CHASE BANK, N.A., as Administrative Agent.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. as the Company and JPMORGAN CHASE BANK, N.A. as Trustee Senior Indenture Dated as of __, 20__Charles River Laboratories International Inc • August 9th, 2006 • Biological products, (no disgnostic substances) • New York
Company FiledAugust 9th, 2006 Industry JurisdictionSENIOR INDENTURE, dated as of______ __, 200__, between Charles River Laboratories International, Inc., a Delaware corporation, as the Company, and JPMORGAN CHASE BANK, N.A., a national banking association, as Trustee.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. as the Company and U.S. BANK NATIONAL ASSOCIATION as Trustee Senior Indenture Dated as of ______ __, 20__Senior Indenture • May 9th, 2018 • Charles River Laboratories International Inc • Services-commercial physical & biological research • New York
Contract Type FiledMay 9th, 2018 Company Industry JurisdictionSENIOR INDENTURE, dated as of ______ __, 20__, between Charles River Laboratories International, Inc., a Delaware corporation, as the Company, and U.S. Bank National Association, a national banking association, as Trustee.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. as the Company and U.S. BANK NATIONAL ASSOCIATION as TrusteeCharles River Laboratories International Inc • May 9th, 2018 • Services-commercial physical & biological research • New York
Company FiledMay 9th, 2018 Industry JurisdictionSUBORDINATED INDENTURE, dated as of ______ __, 20__, between Charles River Laboratories International, Inc., a Delaware corporation, as the Company, and U.S. Bank National Association, a national banking association, as Trustee.
FOURTH AMENDED AND RESTATED CREDIT AGREEMENT dated as of September 23, 2011 among CHARLES RIVER LABORATORIES INTERNATIONAL, INC., The Subsidiary Borrower Party Hereto, The Lenders Party Hereto, JPMORGAN CHASE BANK, N.A., as Administrative Agent, BANK...Credit Agreement • September 23rd, 2011 • Charles River Laboratories International Inc • Services-commercial physical & biological research • New York
Contract Type FiledSeptember 23rd, 2011 Company Industry JurisdictionFOURTH AMENDED AND RESTATED CREDIT AGREEMENT, dated as of September 23, 2011, among CHARLES RIVER LABORATORIES INTERNATIONAL, INC., the Subsidiary Borrower party hereto, the Lenders party hereto and JPMORGAN CHASE BANK, N.A., as Administrative Agent.
Senior Indenture Dated as of ______ __, 20__Charles River Laboratories International Inc • August 4th, 2009 • Services-commercial physical & biological research • New York
Company FiledAugust 4th, 2009 Industry JurisdictionSENIOR INDENTURE, dated as of ______ __, 200__, between Charles River Laboratories International, Inc., a Delaware corporation, as the Company, and U.S. Bank National Association, a national banking association, as Trustee.
EIGHTH AMENDED AND RESTATED CREDIT AGREEMENT dated as of March 26, 2018 among CHARLES RIVER LABORATORIES INTERNATIONAL, INC., The Subsidiary Borrowers Party Hereto, The Lenders Party Hereto, JPMORGAN CHASE BANK, N.A., as Administrative Agent BanK of...Credit Agreement • March 26th, 2018 • Charles River Laboratories International Inc • Services-commercial physical & biological research • New York
Contract Type FiledMarch 26th, 2018 Company Industry JurisdictionEIGHTH AMENDED AND RESTATED CREDIT AGREEMENT, dated as of March 26, 2018, among CHARLES RIVER LABORATORIES INTERNATIONAL, INC., the Subsidiary Borrowers party hereto, the Lenders party hereto and JPMORGAN CHASE BANK, N.A., as Administrative Agent.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. as Issuer AND U.S. BANK NATIONAL ASSOCIATION as Trustee INDENTURE Dated as of June 12, 2006 2.25% Convertible Senior Notes due 2013Charles River Laboratories International Inc • June 12th, 2006 • Biological products, (no disgnostic substances) • New York
Company FiledJune 12th, 2006 Industry JurisdictionINDENTURE dated as of June 12, 2006 between Charles River Laboratories International, Inc., a Delaware corporation, as issuer (hereinafter sometimes called the “Company”, as more fully set forth in Section 1.01), and U.S. Bank National Association, a national banking association organized under the laws of the United States, as trustee (hereinafter sometimes called the “Trustee”, as more fully set forth in Section 1.01).
FORM OF CHARLES RIVER LABORATORIES INTERNATIONAL, INC. PERFORMANCE SHARE UNIT AWARD AGREEMENT (the “Award Agreement”)Performance Share Unit Award Agreement • August 5th, 2020 • Charles River Laboratories International, Inc. • Services-commercial physical & biological research • Delaware
Contract Type FiledAugust 5th, 2020 Company Industry JurisdictionThis Performance Share Unit Award (the “Award”) is granted as of May 29, 2020 by Charles River Laboratories International, Inc. (the “Company”) to «FN_» «LN_» (the “Participant”) on the terms and conditions as set forth in this Award Agreement and in the 2018 Incentive Plan (as amended from time to time, the “Plan”). All capitalized terms used herein shall have the meaning specified in the Plan, unless another meaning is specified herein.
EXHIBIT 99.7 August 13, 2004 Charles River Laboratories International, Inc. 251 Ballardvale Street Wilmington, Massachusetts 01887 Re: Registration Statement on Form S-4 Ladies and Gentlemen: Reference is hereby made to the Agreement and Plan of...Charles River Laboratories International Inc • August 16th, 2004 • Biological products, (no disgnostic substances)
Company FiledAugust 16th, 2004 Industry
EXHIBIT 4.9 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 3 1/2% SENIOR CONVERTIBLE Debentures DUE 2022 REGISTRATION RIGHTS AGREEMENTCharles River Laboratories International Inc • March 27th, 2002 • Biological products, (no disgnostic substances) • New York
Company FiledMarch 27th, 2002 Industry Jurisdiction
AGREEMENT AND PLAN OF MERGER BY AND AMONG Charles River Laboratories INTERNATIONAL, INC. Forest Acquisition Corporation, ACP MOUNTAIN HOLDINGS, INC. and AVISTA CAPITAL PARTNERS IV GP, LP, solely in its capacity as the Stockholders’ Representative...Agreement and Plan of Merger • February 13th, 2018 • Charles River Laboratories International Inc • Services-commercial physical & biological research • Delaware
Contract Type FiledFebruary 13th, 2018 Company Industry JurisdictionThis AGREEMENT AND PLAN OF MERGER, dated February 12, 2018 (this “Agreement”), is made and entered into by and among Charles River Laboratories International, Inc., a Delaware corporation (“Buyer”), Forest Acquisition Corporation, a Delaware corporation and a direct or indirect wholly-owned Subsidiary of Buyer or its Affiliates (“Merger Sub”), ACP Mountain Holdings, Inc., a Delaware corporation (the “Company”), and, solely in its capacity as the Stockholders’ Representative pursuant to Section 10.16 hereof, Avista Capital Partners GP, LP, a Delaware limited partnership (the “Stockholders’ Representative”). Buyer, Merger Sub, the Company and the Stockholders’ Representative (solely for purposes of Section 10.16) are sometimes individually referred to in this Agreement as a “Party” and collectively as the “Parties”. Capitalized terms used in this Agreement shall have the meanings ascribed to them in Exhibit A attached hereto.